
Matrubials YC 지원서
Matrubials은(는) Summer 2021 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.
- YC 배치
- Summer 2021
- 산업
- HealthcareDrug Discovery and Delivery
- 팀 규모
- 4
- 상태
- Active
- 출시됨
- 2021
창업자
Bruce GermanFounder
Carlito LebrillaFounder
David MillsFounder
Matrubials의 사업 내용
Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk can be developed into therapeutics geared towards all-age diseases. Our first indication is bacterial vaginosis, a bacterial dysbiosis related inflammation that results in recurrent infections, disruption of homeostasis and long-term clinical complications in women of reproductive age, including but not limited to preterm births, fertility issues and increased rates of STDs. Our next inflection point is the evaluation of rapidly acting and selective candidate peptides in pre-clinical host impact and early safety studies, which can aid clinical and portfolio development towards topical applications.
Matrubials의 YC 지원서, 재구성됨
Y Combinator 지원
Matrubials, Summer 2021 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Matrubials
Milk-inspired therapeutics for infectious diseases
We are developing antimicrobial peptides derived from human milk to treat bacterial infections. Our lead program targets bacterial vaginosis, aiming to restore microbial balance and prevent recurrent infections and inflammation that affect women's reproductive health. These peptides act selectively to avoid disrupting beneficial bacteria and offer a novel treatment approach against antimicrobial resistance.
We live and work in Davis, CA. After YC, the company will remain based here to leverage local research connections and our core scientific team.
Davis hosts our founders and is near key research institutions. Staying here maintains continuity in science and development and supports our focused approach on milk-based therapeutics.
전체 지원서에서 21개의 추가 답변
Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.
자주 묻는 질문
Matrubials의 실제 YC 지원서인가요?
아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Matrubials의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Matrubials과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.
Matrubials은(는) 어떤 YC 배치에 있었나요?
Matrubials은(는) Y Combinator Summer 2021 배치에 참여했습니다.
Matrubials은(는) 누가 설립했나요?
Matrubials은(는) Bruce German, Carlito Lebrilla, David Mills(이)가 설립했습니다.
Matrubials은(는) 무엇을 하나요?
Developing milk-inspired therapeutics for infectious diseases
전체 재구성된 지원서를 어떻게 읽나요?
무료 Round Funded 계정을 만드세요. Matrubials의 전체 26개 질문 버전 지원서와 모든 YC 배치 지원서는 YC Insights에서 확인할 수 있습니다.